Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile

被引:49
作者
Semple, Graeme [1 ]
Lehmann, Juerg [1 ]
Wong, Amy [1 ]
Ren, Albert [1 ]
Bruce, Marc [1 ]
Shin, Young-Jun [1 ]
Sage, Carleton R. [1 ]
Morgan, Michael [2 ]
Chen, Wei-Chao [2 ]
Sebring, Kristen [3 ]
Chu, Zhi-Liang [3 ]
Leonard, James N. [3 ]
Al-Shamma, Hussein [3 ]
Grottick, Andrew J. [3 ]
Du, Fuyong [4 ]
Liang, Yin [4 ]
Demarest, Keith [4 ]
Jones, Robert M. [1 ]
机构
[1] Arena Pharmaceut, Med Chem, San Diego, CA 92121 USA
[2] Arena Pharmaceut, DMPK, San Diego, CA 92121 USA
[3] Arena Pharmaceut, Discovery Biol, San Diego, CA 92121 USA
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
关键词
GPR119; GPCR; Diabetes; Lead optimization; GLYCEMIC CONTROL; G-PROTEIN-COUPLED-RECEPTOR-119; RELEASE; POTENT;
D O I
10.1016/j.bmcl.2011.12.092
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design and synthesis of a second generation GPR119-agonist clinical candidate for the treatment of diabetes is described. Compound 16 (APD597, JNJ-38431055) was selected for preclinical development based on a good balance between agonist potency, intrinsic activity and in particular on its good solubility and reduced drug-drug interaction potential. In addition, extensive in vivo studies showed a more favorable metabolic profile that may avoid the generation of long lasting metabolites with the potential to accumulate in clinical studies. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1750 / 1755
页数:6
相关论文
共 16 条
[1]   A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release [J].
Chu, Zhi-Liang ;
Carroll, Chris ;
Alfonso, Jean ;
Gutierrez, Veronica ;
He, Hongmei ;
Lucman, Annette ;
Pedraza, Melinda ;
Mondala, Helen ;
Gao, Hui ;
Bagnol, Didier ;
Chen, Ruoping ;
Jones, Robert M. ;
Behan, Dominic P. ;
Leonard, James .
ENDOCRINOLOGY, 2008, 149 (05) :2038-2047
[2]   A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release [J].
Chu, Zhi-Liang ;
Jones, Robert M. ;
He, Hongmei ;
Carroll, Chris ;
Gutierrez, Veronica ;
Lucman, Annette ;
Moloney, Molly ;
Gao, Hui ;
Mondala, Helen ;
Bagnol, Didier ;
Unett, David ;
Liang, Yin ;
Demarest, Keith ;
Semple, Graeme ;
Behan, Dominic P. ;
Leonard, James .
ENDOCRINOLOGY, 2007, 148 (06) :2601-2609
[3]   THE SIGNIFICANCE OF GPR119 AGONISTS AS A FUTURE TREATMENT FOR TYPE 2 DIABETES [J].
Dhayal, Shalinee ;
Morgan, Noel G. .
DRUG NEWS & PERSPECTIVES, 2010, 23 (07) :418-424
[4]  
Jones R. M., 2007, [No title captured], Patent No. [WO 2007035355, 2007035355]
[5]  
Jones R. M., 2005, WO Pat. Appl., Patent No. 2005121121
[6]  
Jones R.M., 2010, 239 ACS NAT M MARCH
[7]  
Jones R. M., 2008, WO Pat. Appl., Patent No. 2008005576
[8]   The Emergence of GPR119 Agonists as Anti-Diabetic Agents [J].
Jones, Robert M. ;
Leonard, James N. .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44, 2009, 44 :149-170
[9]   Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects [J].
Katz, L. B. ;
Gambale, J. J. ;
Rothenberg, P. L. ;
Vanapalli, S. R. ;
Vaccaro, N. ;
Xi, L. ;
Polidori, D. C. ;
Vets, E. ;
Sarich, T. C. ;
Stein, P. P. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (05) :685-692
[10]   Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response [J].
McClure, Kim F. ;
Darout, Etzer ;
Guimaraes, Cristiano R. W. ;
DeNinno, Michael P. ;
Mascitti, Vincent ;
Munchhof, Michael J. ;
Robinson, Ralph P. ;
Kohrt, Jeffrey ;
Harris, Anthony R. ;
Moore, Dianna E. ;
Li, Bryan ;
Samp, Lacey ;
Lefker, Bruce A. ;
Futatsugi, Kentaro ;
Kung, Daniel ;
Bonin, Paul D. ;
Cornelius, Peter ;
Wang, Ruduan ;
Salter, Eben ;
Hornby, Sam ;
Kalgutkar, Amit S. ;
Chen, Yue .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) :1948-1952